Filamin-A is required to mediate SST2 effects in pancreatic neuroendocrine tumours

Filamin A (FLNA) Plays an Essential Role in Somatostatin Receptor 2 (SST2) Signaling and Stabilization After Agonist Stimulation in Human and Rat Somatotroph Tumor Cells

(2014) E. Peverelli et al.   ENDOCRINOLOGY

Hypoxia-induced and calpain-dependent cleavage of filamin A regulates the hypoxic response

(2014) X. Zheng et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Biotherapies for GEP-NETs

(2013) Kjell Öberg   BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY

Molecular Pathogenesis of Neuroendocrine Tumors: Implications for Current and Future Therapeutic Approaches

(2013) K. Oberg et al.   CLINICAL CANCER RESEARCH

The dual role of filamin A in cancer: can't live with (too much of) it, can't live without it

(2013) Rosalinda M Savoy et al.   ENDOCRINE-RELATED CANCER

Somatostatin receptors: From signaling to clinical practice

(2013) Marily Theodoropoulou et al.   FRONTIERS IN NEUROENDOCRINOLOGY

Illuminating somatostatin analog action at neuroendocrine tumor receptors

(2013) Jean Claude Reubi et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Complex roles of filamin-A mediated cytoskeleton network in cancer progression

(2013) Jingyin Yue et al.   Cell and Bioscience

Filamin-A Is Essential for Dopamine D2 Receptor Expression and Signaling in Tumorous Lactotrophs

(2012) Erika Peverelli et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy

(2012) Gregg L. Semenza   TRENDS IN PHARMACOLOGICAL SCIENCES

Four proteins governing overangiogenic endothelial cell phenotype in patients with multiple myeloma are plausible therapeutic targets

(2011) S Berardi et al.   ONCOGENE

Somatostatin analogue inhibits the mobility of prostate carcinoma cells: A new therapeutic method for advanced prostate carcinoma

(2010) Tang   INTERNATIONAL JOURNAL OF ONCOLOGY

Filamin A regulates focal adhesion disassembly and suppresses breast cancer cell migration and invasion

(2010) Yingjie Xu et al.   JOURNAL OF EXPERIMENTAL MEDICINE

VEGF Secretion by Neuroendocrine Tumor Cells Is Inhibited by Octreotide and by Inhibitors of the PI3K/AKT/mTOR Pathway

(2010) Karine Villaume et al.   NEUROENDOCRINOLOGY

Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group

(2009) Anja Rinke et al.   JOURNAL OF CLINICAL ONCOLOGY

The role(s) of somatostatin, structurally related peptides and somatostatin receptors in the gastrointestinal tract: a review

(2009) Joeri Van Op den bosch et al.   REGULATORY PEPTIDES